Coeptis Therapeutics Inc. (COEP)
NASDAQ: COEP
· Real-Time Price · USD
13.96
2.48 (21.60%)
At close: Aug 15, 2025, 3:59 PM
13.81
-1.11%
After-hours: Aug 15, 2025, 06:35 PM EDT
Coeptis Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -11.3M | -10.88M | -11.62M | -16.05M | -16.13M | -21M | -20.19M | -19.57M | -26.26M | -37.57M | -37.47M | -37.77M | -30.68M | -13.45M | -27.89M | -21.94M | -19.23M |
Depreciation & Amortization | 1.09M | 1.04M | 1.03M | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1.2M | 947.26K | 697.28K | 447.41K | 1.21K | 848.00 | 481.00 |
Stock-Based Compensation | 2.31M | 1.81M | 1.64M | 950.27K | 452K | 477.5K | 348.99K | 235.69K | 122.39K | n/a | n/a | 1.9M | 1.9M | 1.9M | 1.9M | n/a | n/a |
Other Working Capital | 9.26K | 149.94K | 295.62K | 382.19K | 300.22K | 203.09K | -474.61K | -514.95K | -571.42K | -548.3K | 120.44K | -934.2K | -1.8M | -1.53M | -1.57M | -573.25K | 289.43K |
Other Non-Cash Items | 1.54M | 2.86M | 2.31M | 7.46M | 7.02M | 11.32M | 13.56M | 12.97M | 12.79M | 24.97M | 25.47M | 21.81M | 24.31M | 7.29M | 20.96M | 20.35M | 17.68M |
Deferred Income Tax | n/a | n/a | 807.8K | -286.5K | n/a | n/a | -807.8K | 286.5K | n/a | n/a | n/a | 2.3M | 2.3M | 2.3M | 2.3M | n/a | n/a |
Change in Working Capital | -86.87K | n/a | 826.38K | 1.15M | 1.38M | 1.49M | -312.41K | -388.18K | -532.65K | -550.34K | -707.64K | -3.32M | -3.33M | -2.98M | -1.97M | 539.84K | 477.51K |
Operating Cash Flow | -7.11M | -6.65M | -6.91M | -6.97M | -7.46M | -7.24M | -6.39M | -5.47M | -4.6M | -3.88M | -3.24M | -5.85M | -4.8M | -4.49M | -4.7M | -1.05M | -1.07M |
Capital Expenditures | n/a | n/a | 1.00 | 1.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.05M | -4.05M | -4.05M | -4.05M | 2.00 | 2.00 |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | 333.33K | 200K | 1.00 | 1.00 | -333.33K | -200K | n/a | n/a | -75.75M | -75.75M | -75.75M |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | -43.03M | -43.03M | n/a | n/a | 43.03M | 43.03M | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 42.69M | 42.59M | 42.49M | 250K | -100K | n/a | n/a | -350K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 42.69M | 42.59M | 42.49M | 250K | -100K | n/a | -42.69M | -43.18M | n/a | n/a | 45.75M | 41.83M | -1M | -1M | -79.8M | -75.75M | -75.75M |
Debt Repayment | -1.06M | n/a | 1.06M | 337.5K | 487.5K | -575K | -2.97M | -2.29M | -2.47M | -2.72M | -5.44M | -644.27K | -1.75M | -1.62M | 3.52M | -1.23M | -297.58K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 8.6M | 2.49M | 200K | 250K | 200K | 200K | -141.44K | 4.61M | 48.53M | 48.64M | 47.66M | 44.19M | 357.16K | -50.9K | 1.08M | -215.56K | -298.06K |
Financial Cash Flow | 10.25M | 5.71M | 6.73M | 5.03M | 6.48M | 4.92M | 433.68K | 6.68M | 4.36M | 5.49M | 4.74M | 7.32M | 6.85M | 8.22M | 88.77M | 80.16M | 79.56M |
Net Cash Flow | 3.24M | -936.25K | -274.06K | -1.69M | -1.08M | -2.32M | -5.96M | 866.52K | -237K | 1.61M | 4.56M | 466.99K | 309.1K | 1.98M | 2.61M | 1.71M | 1.83M |
Free Cash Flow | -7.11M | -6.65M | -6.91M | -6.97M | -7.46M | -7.24M | -6.39M | -5.47M | -4.6M | -3.88M | -3.24M | -9.91M | -8.85M | -8.54M | -8.75M | -1.05M | -1.07M |